APA

Riedl M. A., Levy R. J., Suez D., Lockey R. F., Baker J. W., Relan A. & Zuraw B. L. (20130523). Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study. : Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Chicago

Riedl Marc A, Levy Robyn J, Suez Daniel, Lockey Richard F, Baker James W, Relan Anurag and Zuraw Bruce L. 20130523. Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study. : Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Harvard

Riedl M. A., Levy R. J., Suez D., Lockey R. F., Baker J. W., Relan A. and Zuraw B. L. (20130523). Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study. : Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

MLA

Riedl Marc A, Levy Robyn J, Suez Daniel, Lockey Richard F, Baker James W, Relan Anurag and Zuraw Bruce L. Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study. : Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 20130523.